サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1457951

外科手術の世界市場：市場規模・シェア分析 (種類別・提供者別・男女別・年齢層別)、産業需要の予測 (～2030年)

Surgical Procedures Market Size and Share Analysis by Type, Provider, Gender, Age Group - Global Industry Demand Forecast to 2030
出版日: | 発行: Prescient & Strategic Intelligence | ページ情報: 英文 260 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.95円
外科手術の世界市場：市場規模・シェア分析 (種類別・提供者別・男女別・年齢層別)、産業需要の予測 (～2030年)
出版日: 2024年02月01日
発行: Prescient & Strategic Intelligence
ページ情報: 英文 260 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の外科手術市場は、2023年に1億1,000万件、2030年に1億3,750万件と、3.3%のCAGRで拡大しています。

この主な理由は、慢性疾患、特にがんやCVDの発症率が急上昇していること、高齢者人口の増加と相まっていることです。

市場をリードする北米

2023年の市場シェアは、北米が50%と最大でした。これは、心臓疾患、整形外科疾患、消化器疾患のような疾患の罹患率の上昇とともに、発達した医療制度が存在するためです。

アジア太平洋地域は今後数年間、約3.5%の最速速度で成長します。これは、慢性疾患に対する意識の高まり、開発された手術技術の登場、神経疾患や外傷の発生率の増加、医療・メディカルツーリズム部門の隆盛などが背景にあります。

セグメント別の洞察

2023年には、産科・婦人科カテゴリーが約30%のシェアを占め、最大のシェアを占めました。これは、多嚢胞性卵巣症候群 (PCOS)、子宮内膜症、卵巣嚢腫、慢性骨盤痛、卵巣・子宮がん、骨盤内炎症性疾患、子宮筋腫、子宮腺筋症などの婦人科疾患の発生率が増加しているためです。

一方、眼科領域は、今後数年間で、約3.7%という最も速いペースで進歩すると思われます。これは主に、緑内障、糖尿病性網膜症、白内障などの様々な眼科疾患の発生が増加しているためです。

2023年には、病院が約45%のシェアで最大のエンドユーザーカテゴリーであり、この10年間を通じて最大であり続けると思われます。これは、世界的にこれらの医療環境で実施される手術件数が多いこと、さまざまな慢性疾患の有病率が上昇していることに拠ります。

当レポートでは、世界の外科手術の市場について分析し、市場の基本構造・最新情勢や主な促進・抑制要因、世界全体および地域別・主要国の市場規模の動向見通し (件数・金額ベース、2017～2030年)、種類別・提供者別・男女別・年齢層別の詳細動向、現在の市場競争の状況、主要企業のプロファイルなどを調査しております。

目次

第1章 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場指標

第5章 業界の展望

  • 市場力学
    • 動向
    • 促進要因
    • 抑制要因/課題
    • 促進要因/抑制要因の影響分析
  • 新型コロナウイルス感染症 (COVID-19) の影響
  • ポーターのファイブフォース分析

第6章 世界市場

  • 概要
  • 市場規模：種類別 (2017～2030年)
  • 市場収益：種類別 (2017～2030年)
  • 市場規模：提供者別 (2017～2030年)
  • 市場収益：提供者別 (2017～2030年)
  • 市場規模：男女別 (2017～2030年)
  • 市場収益：男女別 (2017～2030年)
  • 市場規模：年齢層別 (2017～2030年)
  • 市場収益：年齢層別 (2017～2030年)
  • 市場規模：地域別 (2017～2030年)
  • 市場収益：地域別 (2017～2030年)

第7章 北米市場

  • 概要
  • 市場規模：種類別 (2017～2030年)
  • 市場収益：種類別 (2017～2030年)
  • 市場規模：提供者別 (2017～2030年)
  • 市場収益：提供者別 (2017～2030年)
  • 市場規模：男女別 (2017～2030年)
  • 市場収益：男女別 (2017～2030年)
  • 市場規模：年齢層別 (2017～2030年)
  • 市場収益：年齢層別 (2017～2030年)
  • 市場規模：国別 (2017～2030年)
  • 市場収益：国別 (2017～2030年)

第8章 欧州市場

第9章 アジア太平洋市場

第10章 ラテンアメリカ市場

第11章 中東・アフリカ (MEA) 市場

第12章 米国市場

  • 概要
  • 市場規模：種類別 (2017～2030年)
  • 市場収益：種類別 (2017～2030年)
  • 市場規模：提供者別 (2017～2030年)
  • 市場収益：提供者別 (2017～2030年)
  • 市場規模：男女別 (2017～2030年)
  • 市場収益：男女別 (2017～2030年)
  • 市場規模：年齢層別 (2017～2030年)
  • 市場収益：年齢層別 (2017～2030年)

第13章 カナダ市場

第14章 ドイツ市場

第15章 フランス市場

第16章 英国市場

第17章 イタリア市場

第18章 スペイン市場

第19章 日本市場

第20章 中国市場

第21章 インド市場

第22章 オーストラリア市場

第23章 韓国市場

第24章 ブラジル市場

第25章 メキシコ市場

第26章 サウジアラビア市場

第27章 南アフリカ市場

第28章 アラブ首長国連邦 (UAE) 市場

第29章 競合情勢

  • 市場参入企業とその提供製品/サービスの一覧
  • 主要企業の競合ベンチマーク
  • 主要企業の製品ベンチマーク
  • 最近の戦略展開状況

第30章 企業プロファイル

  • Stryker Corporation
  • Becton, Dickinson and Company
  • Olympus Corporation
  • Zimmer Biomet
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Smith & Nephew
  • Medtronic plc
  • Cook Medical
  • CONMED Corporation

第31章 付録

目次
Product Code: 12799

The surgical procedures market was 110.0 million procedures in 2023, and it will increase to 137.5 million, advancing at a 3.3% compound annual growth rate, by 2030.

This is mainly because of the surging incidence of chronic disorders, particularly cancer and CVDs; coupled with the increasing elderly population.

Aging people are more vulnerable to chronic ailments like diabetes, cancer, cardiovascular diseases, and neurological disorders, which led to the growing need for surgical procedures. Likewise, the low levels of immunity make the elderly population more susceptible to infections, therefore resulting in an increase in the number of surgical procedures.

As per the World Health Organization, there were an estimated 20 million new cases of cancer and 9.7 million deaths in 2022.

The projected number of individuals who were alive within 5 years following a cancer diagnosis was 53.5 million.

Approximately 1 out of 5 people develop cancer in their lifetime, around 1 out of 12 women and 1 out of 9 men die from the ailment.

Moreover, as per a report, worldwide death counts because of CVD increase to 19.8 million in 2022 from 12.4 million in 1990 reflecting worldwide population growth as well as aging.

Furthermore, the technological improvements in the surgical process will further assist the growth of this industry in the years to come.

The high count of outpatient surgeries is offering significant growth opportunities to the industry. Outpatient surgeries do not mandate an overnight stay at the hospital. Currently, medical procedures are increasing at outpatient facilities due to technological improvements, counting the arrival of minimally invasive surgeries, and the accessibility of value-based care incentives.

North America is Leading Market

North America accounted for the largest share of the industry in 2023, of 50%. This is because of the existence of developed healthcare systems, along with the rising incidence of diseases like cardiac, orthopedic, and gastrointestinal disorders.

Moreover, the higher acceptance rate of cutting-edge devices as well as the change in the fondness toward outpatient surgeries are also aiding the regional industry growth.

APAC will advance at the fastest rate of approximately 3.5% in the coming years. This is because of the rising consciousness of chronic disorders, the arrival of developed surgical technologies, the increasing incidence of neurological disorders and traumatic injuries, and the flourishing healthcare and medical tourism sectors, in this region.

Segmentation Insights

The obstetric & gynecological category was the largest contributor to the industry in 2023, with approximately 30% share. This is ascribed to the increasing incidence of gynecological disorders, including polycystic ovary syndrome (PCOS), endometriosis, ovarian cysts, chronic pelvic pain, ovarian and uterine cancer, pelvic inflammatory disease, uterine fibroids, and adenomyosis.

Whereas, the ophthalmic category will advance at the fastest rate, of approximately 3.7%, in the years to come. This can be mainly because of the increasing occurrence of various ophthalmic disorders, such as glaucoma, diabetic retinopathy, and cataracts.

The hospital was the largest end user category in 2023, with approximately 45% share, and it will remain the largest throughout this decade. This is because of the high count of surgeries carried out in these healthcare settings globally; and the rising prevalence of various chronic ailments.

With the surging occurrence of chronic diseases across the globe, the need for surgical procedures will continue to increase in the years to come.

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by type
    • 1.4.2. Market size breakdown, by provider
    • 1.4.3. Market size breakdown, by gender
    • 1.4.4. Market size breakdown, by age group
    • 1.4.5. Market size breakdown, by region
    • 1.4.6. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Volume
    • 1.5.2. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

  • 5.1. Market Dynamics
    • 5.1.1. Trends
    • 5.1.2. Drivers
    • 5.1.3. Restraints/challenges
    • 5.1.4. Impact analysis of drivers/restraints
  • 5.2. Impact of COVID-19
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining power of buyers
    • 5.3.2. Bargaining power of suppliers
    • 5.3.3. Threat of new entrants
    • 5.3.4. Intensity of rivalry
    • 5.3.5. Threat of substitutes

Chapter 6. Global Market

  • 6.1. Overview
  • 6.2. Market Volume, by Type (2017-2030)
  • 6.3. Market Revenue, by Type (2017-2030)
  • 6.4. Market Volume, by Provider (2017-2030)
  • 6.5. Market Revenue, by Provider (2017-2030)
  • 6.6. Market Volume, by Gender (2017-2030)
  • 6.7. Market Revenue, by Gender (2017-2030)
  • 6.8. Market Volume, by Age Group (2017-2030)
  • 6.9. Market Revenue, by Age Group (2017-2030)
  • 6.10. Market Volume, by Region (2017-2030)
  • 6.11. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

  • 7.1. Overview
  • 7.2. Market Volume, by Type (2017-2030)
  • 7.3. Market Revenue, by Type (2017-2030)
  • 7.4. Market Volume, by Provider (2017-2030)
  • 7.5. Market Revenue, by Provider (2017-2030)
  • 7.6. Market Volume, by Gender (2017-2030)
  • 7.7. Market Revenue, by Gender (2017-2030)
  • 7.8. Market Volume, by Age Group (2017-2030)
  • 7.9. Market Revenue, by Age Group (2017-2030)
  • 7.10. Market Volume, by Country (2017-2030)
  • 7.11. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

  • 8.1. Overview
  • 8.2. Market Volume, by Type (2017-2030)
  • 8.3. Market Revenue, by Type (2017-2030)
  • 8.4. Market Volume, by Provider (2017-2030)
  • 8.5. Market Revenue, by Provider (2017-2030)
  • 8.6. Market Volume, by Gender (2017-2030)
  • 8.7. Market Revenue, by Gender (2017-2030)
  • 8.8. Market Volume, by Age Group (2017-2030)
  • 8.9. Market Revenue, by Age Group (2017-2030)
  • 8.10. Market Volume, by Country (2017-2030)
  • 8.11. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

  • 9.1. Overview
  • 9.2. Market Volume, by Type (2017-2030)
  • 9.3. Market Revenue, by Type (2017-2030)
  • 9.4. Market Volume, by Provider (2017-2030)
  • 9.5. Market Revenue, by Provider (2017-2030)
  • 9.6. Market Volume, by Gender (2017-2030)
  • 9.7. Market Revenue, by Gender (2017-2030)
  • 9.8. Market Volume, by Age Group (2017-2030)
  • 9.9. Market Revenue, by Age Group (2017-2030)
  • 9.10. Market Volume, by Country (2017-2030)
  • 9.11. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

  • 10.1. Overview
  • 10.2. Market Volume, by Type (2017-2030)
  • 10.3. Market Revenue, by Type (2017-2030)
  • 10.4. Market Volume, by Provider (2017-2030)
  • 10.5. Market Revenue, by Provider (2017-2030)
  • 10.6. Market Volume, by Gender (2017-2030)
  • 10.7. Market Revenue, by Gender (2017-2030)
  • 10.8. Market Volume, by Age Group (2017-2030)
  • 10.9. Market Revenue, by Age Group (2017-2030)
  • 10.10. Market Volume, by Country (2017-2030)
  • 10.11. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

  • 11.1. Overview
  • 11.2. Market Volume, by Type (2017-2030)
  • 11.3. Market Revenue, by Type (2017-2030)
  • 11.4. Market Volume, by Provider (2017-2030)
  • 11.5. Market Revenue, by Provider (2017-2030)
  • 11.6. Market Volume, by Gender (2017-2030)
  • 11.7. Market Revenue, by Gender (2017-2030)
  • 11.8. Market Volume, by Age Group (2017-2030)
  • 11.9. Market Revenue, by Age Group (2017-2030)
  • 11.10. Market Volume, by Country (2017-2030)
  • 11.11. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

  • 12.1. Overview
  • 12.2. Market Volume, by Type (2017-2030)
  • 12.3. Market Revenue, by Type (2017-2030)
  • 12.4. Market Volume, by Provider (2017-2030)
  • 12.5. Market Revenue, by Provider (2017-2030)
  • 12.6. Market Volume, by Gender (2017-2030)
  • 12.7. Market Revenue, by Gender (2017-2030)
  • 12.8. Market Volume, by Age Group (2017-2030)
  • 12.9. Market Revenue, by Age Group (2017-2030)

Chapter 13. Canada Market

  • 13.1. Overview
  • 13.2. Market Volume, by Type (2017-2030)
  • 13.3. Market Revenue, by Type (2017-2030)
  • 13.4. Market Volume, by Provider (2017-2030)
  • 13.5. Market Revenue, by Provider (2017-2030)
  • 13.6. Market Volume, by Gender (2017-2030)
  • 13.7. Market Revenue, by Gender (2017-2030)
  • 13.8. Market Volume, by Age Group (2017-2030)
  • 13.9. Market Revenue, by Age Group (2017-2030)

Chapter 14. Germany Market

  • 14.1. Overview
  • 14.2. Market Volume, by Type (2017-2030)
  • 14.3. Market Revenue, by Type (2017-2030)
  • 14.4. Market Volume, by Provider (2017-2030)
  • 14.5. Market Revenue, by Provider (2017-2030)
  • 14.6. Market Volume, by Gender (2017-2030)
  • 14.7. Market Revenue, by Gender (2017-2030)
  • 14.8. Market Volume, by Age Group (2017-2030)
  • 14.9. Market Revenue, by Age Group (2017-2030)

Chapter 15. France Market

  • 15.1. Overview
  • 15.2. Market Volume, by Type (2017-2030)
  • 15.3. Market Revenue, by Type (2017-2030)
  • 15.4. Market Volume, by Provider (2017-2030)
  • 15.5. Market Revenue, by Provider (2017-2030)
  • 15.6. Market Volume, by Gender (2017-2030)
  • 15.7. Market Revenue, by Gender (2017-2030)
  • 15.8. Market Volume, by Age Group (2017-2030)
  • 15.9. Market Revenue, by Age Group (2017-2030)

Chapter 16. U.K. Market

  • 16.1. Overview
  • 16.2. Market Volume, by Type (2017-2030)
  • 16.3. Market Revenue, by Type (2017-2030)
  • 16.4. Market Volume, by Provider (2017-2030)
  • 16.5. Market Revenue, by Provider (2017-2030)
  • 16.6. Market Volume, by Gender (2017-2030)
  • 16.7. Market Revenue, by Gender (2017-2030)
  • 16.8. Market Volume, by Age Group (2017-2030)
  • 16.9. Market Revenue, by Age Group (2017-2030)

Chapter 17. Italy Market

  • 17.1. Overview
  • 17.2. Market Volume, by Type (2017-2030)
  • 17.3. Market Revenue, by Type (2017-2030)
  • 17.4. Market Volume, by Provider (2017-2030)
  • 17.5. Market Revenue, by Provider (2017-2030)
  • 17.6. Market Volume, by Gender (2017-2030)
  • 17.7. Market Revenue, by Gender (2017-2030)
  • 17.8. Market Volume, by Age Group (2017-2030)
  • 17.9. Market Revenue, by Age Group (2017-2030)

Chapter 18. Spain Market

  • 18.1. Overview
  • 18.2. Market Volume, by Type (2017-2030)
  • 18.3. Market Revenue, by Type (2017-2030)
  • 18.4. Market Volume, by Provider (2017-2030)
  • 18.5. Market Revenue, by Provider (2017-2030)
  • 18.6. Market Volume, by Gender (2017-2030)
  • 18.7. Market Revenue, by Gender (2017-2030)
  • 18.8. Market Volume, by Age Group (2017-2030)
  • 18.9. Market Revenue, by Age Group (2017-2030)

Chapter 19. Japan Market

  • 19.1. Overview
  • 19.2. Market Volume, by Type (2017-2030)
  • 19.3. Market Revenue, by Type (2017-2030)
  • 19.4. Market Volume, by Provider (2017-2030)
  • 19.5. Market Revenue, by Provider (2017-2030)
  • 19.6. Market Volume, by Gender (2017-2030)
  • 19.7. Market Revenue, by Gender (2017-2030)
  • 19.8. Market Volume, by Age Group (2017-2030)
  • 19.9. Market Revenue, by Age Group (2017-2030)

Chapter 20. China Market

  • 20.1. Overview
  • 20.2. Market Volume, by Type (2017-2030)
  • 20.3. Market Revenue, by Type (2017-2030)
  • 20.4. Market Volume, by Provider (2017-2030)
  • 20.5. Market Revenue, by Provider (2017-2030)
  • 20.6. Market Volume, by Gender (2017-2030)
  • 20.7. Market Revenue, by Gender (2017-2030)
  • 20.8. Market Volume, by Age Group (2017-2030)
  • 20.9. Market Revenue, by Age Group (2017-2030)

Chapter 21. India Market

  • 21.1. Overview
  • 21.2. Market Volume, by Type (2017-2030)
  • 21.3. Market Revenue, by Type (2017-2030)
  • 21.4. Market Volume, by Provider (2017-2030)
  • 21.5. Market Revenue, by Provider (2017-2030)
  • 21.6. Market Volume, by Gender (2017-2030)
  • 21.7. Market Revenue, by Gender (2017-2030)
  • 21.8. Market Volume, by Age Group (2017-2030)
  • 21.9. Market Revenue, by Age Group (2017-2030)

Chapter 22. Australia Market

  • 22.1. Overview
  • 22.2. Market Volume, by Type (2017-2030)
  • 22.3. Market Revenue, by Type (2017-2030)
  • 22.4. Market Volume, by Provider (2017-2030)
  • 22.5. Market Revenue, by Provider (2017-2030)
  • 22.6. Market Volume, by Gender (2017-2030)
  • 22.7. Market Revenue, by Gender (2017-2030)
  • 22.8. Market Volume, by Age Group (2017-2030)
  • 22.9. Market Revenue, by Age Group (2017-2030)

Chapter 23. South Korea Market

  • 23.1. Overview
  • 23.2. Market Volume, by Type (2017-2030)
  • 23.3. Market Revenue, by Type (2017-2030)
  • 23.4. Market Volume, by Provider (2017-2030)
  • 23.5. Market Revenue, by Provider (2017-2030)
  • 23.6. Market Volume, by Gender (2017-2030)
  • 23.7. Market Revenue, by Gender (2017-2030)
  • 23.8. Market Volume, by Age Group (2017-2030)
  • 23.9. Market Revenue, by Age Group (2017-2030)

Chapter 24. Brazil Market

  • 24.1. Overview
  • 24.2. Market Volume, by Type (2017-2030)
  • 24.3. Market Revenue, by Type (2017-2030)
  • 24.4. Market Volume, by Provider (2017-2030)
  • 24.5. Market Revenue, by Provider (2017-2030)
  • 24.6. Market Volume, by Gender (2017-2030)
  • 24.7. Market Revenue, by Gender (2017-2030)
  • 24.8. Market Volume, by Age Group (2017-2030)
  • 24.9. Market Revenue, by Age Group (2017-2030)

Chapter 25. Mexico Market

  • 25.1. Overview
  • 25.2. Market Volume, by Type (2017-2030)
  • 25.3. Market Revenue, by Type (2017-2030)
  • 25.4. Market Volume, by Provider (2017-2030)
  • 25.5. Market Revenue, by Provider (2017-2030)
  • 25.6. Market Volume, by Gender (2017-2030)
  • 25.7. Market Revenue, by Gender (2017-2030)
  • 25.8. Market Volume, by Age Group (2017-2030)
  • 25.9. Market Revenue, by Age Group (2017-2030)

Chapter 26. Saudi Arabia Market

  • 26.1. Overview
  • 26.2. Market Volume, by Type (2017-2030)
  • 26.3. Market Revenue, by Type (2017-2030)
  • 26.4. Market Volume, by Provider (2017-2030)
  • 26.5. Market Revenue, by Provider (2017-2030)
  • 26.6. Market Volume, by Gender (2017-2030)
  • 26.7. Market Revenue, by Gender (2017-2030)
  • 26.8. Market Volume, by Age Group (2017-2030)
  • 26.9. Market Revenue, by Age Group (2017-2030)

Chapter 27. South Africa Market

  • 27.1. Overview
  • 27.2. Market Volume, by Type (2017-2030)
  • 27.3. Market Revenue, by Type (2017-2030)
  • 27.4. Market Volume, by Provider (2017-2030)
  • 27.5. Market Revenue, by Provider (2017-2030)
  • 27.6. Market Volume, by Gender (2017-2030)
  • 27.7. Market Revenue, by Gender (2017-2030)
  • 27.8. Market Volume, by Age Group (2017-2030)
  • 27.9. Market Revenue, by Age Group (2017-2030)

Chapter 28. U.A.E. Market

  • 28.1. Overview
  • 28.2. Market Volume, by Type (2017-2030)
  • 28.3. Market Revenue, by Type (2017-2030)
  • 28.4. Market Volume, by Provider (2017-2030)
  • 28.5. Market Revenue, by Provider (2017-2030)
  • 28.6. Market Volume, by Gender (2017-2030)
  • 28.7. Market Revenue, by Gender (2017-2030)
  • 28.8. Market Volume, by Age Group (2017-2030)
  • 28.9. Market Revenue, by Age Group (2017-2030)

Chapter 29. Competitive Landscape

  • 29.1. List of Market Players and their Offerings
  • 29.2. Competitive Benchmarking of Key Players
  • 29.3. Product Benchmarking of Key Players
  • 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

  • 30.1. Stryker Corporation
    • 30.1.1. Business overview
    • 30.1.2. Product and service offerings
    • 30.1.3. Key financial summary
  • 30.2. Becton, Dickinson and Company
    • 30.2.1. Business overview
    • 30.2.2. Product and service offerings
    • 30.2.3. Key financial summary
  • 30.3. Olympus Corporation
    • 30.3.1. Business overview
    • 30.3.2. Product and service offerings
    • 30.3.3. Key financial summary
  • 30.4. Zimmer Biomet
    • 30.4.1. Business overview
    • 30.4.2. Product and service offerings
    • 30.4.3. Key financial summary
  • 30.5. Abbott Laboratories
    • 30.5.1. Business overview
    • 30.5.2. Product and service offerings
    • 30.5.3. Key financial summary
  • 30.6. Boston Scientific Corporation
    • 30.6.1. Business overview
    • 30.6.2. Product and service offerings
    • 30.6.3. Key financial summary
  • 30.7. Smith & Nephew
    • 30.7.1. Business overview
    • 30.7.2. Product and service offerings
    • 30.7.3. Key financial summary
  • 30.8. Medtronic plc
    • 30.8.1. Business overview
    • 30.8.2. Product and service offerings
    • 30.8.3. Key financial summary
  • 30.9. Cook Medical
    • 30.9.1. Business overview
    • 30.9.2. Product and service offerings
    • 30.9.3. Key financial summary
  • 30.10. CONMED Corporation
    • 30.10.1. Business overview
    • 30.10.2. Product and service offerings
    • 30.10.3. Key financial summary

Chapter 31. Appendix

  • 31.1. Abbreviations
  • 31.2. Sources and References
  • 31.3. Related Reports